IA
ABBV icon

Inspire Advisors’s AbbVie ABBV Stock Holding History

Inspire Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$425K Buy
1,956
+358
+22% +$79.4K 0.03% 399
2025
Q4 		$365K Sell
1,598
-20
-1% -$4.56K 0.03% 380
2025
Q3 		$375K Buy
1,618
+40
+3% +$8.15K 0.04% 348
2025
Q2 		$293K Sell
1,578
-75
-5% -$13.9K 0.03% 382
2025
Q1 		$346K Buy
1,653
+41
+3% +$7.97K 0.04% 323
2024
Q4 		$286K Sell
1,612
-12
-0.7% -$2.21K 0.04% 304
2024
Q3 		$321K Buy
1,624
+87
+6% +$16.2K 0.04% 294
2024
Q2 		$264K Buy
1,537
+61
+4% +$10.1K 0.04% 287
2024
Q1 		$269K Sell
1,476
-97
-6% -$16.7K 0.04% 260
2023
Q4 		$244K Buy
+1,573
New +$229K 0.04% 262
2021
Q1 		– Sell
-66
Closed -$7K – 83
2020
Q4 		$7K Buy
+66
New +$6.34K ﹤0.01% 554

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Inspire Advisors's ABBV Position: Q1 2026 in Review

Inspire Advisors increased its AbbVie (ABBV) stake by 22% in Q1 2026, buying an estimated $79.4K and bringing the position to 1,956 shares worth $425K. The position accounts for 0.03% of the portfolio, ranked #399.

Inspire Advisors first reported a position in ABBV in Q4 2020 and has held it in 11 quarters since. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Inspire Advisors held 1,956 shares of AbbVie worth $425K as of Q1 2026.
  • Inspire Advisors bought 358 AbbVie shares in Q1 2026, an estimated $79.4K.
  • AbbVie made up 0.03% of Inspire Advisors's portfolio in Q1 2026, its #399 holding.
  • Inspire Advisors first reported a position in AbbVie in Q4 2020 and has held it in 11 quarters since.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Inspire Advisors's 13F filing for Q1 2026, filed 15 May 2026.